Cytokinetics (CYTK) Current Assets (2010 - 2026)
Cytokinetics (CYTK) reported Current Assets of $1.19 billion for Q3 2026, up 21.5% from $977.35 million a year earlier but down 1.8% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics posted Current Assets of $916.98 million, down 17.2% from FY2024.
- Current Assets has a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- By year, Current Assets came in at $1.11 billion in FY2024 (+76.4%), $628.05 million in FY2023 (-21.0%), $795.19 million in FY2022 (+48.4%) and $535.67 million in FY2021 (+13.0%).
- Five-year quarterly Current Assets spans a low of $535.67 million in Q4 2021 and a high of $1.21 billion in Q2 2026.
- Year over year, Current Assets gained in four of the last eight quarters, with growth averaging 16.7%.
- The high point for year-over-year Current Assets in five years was Q2 2024 (growth of 82.0%); the low point was Q3 2023 (a decline of 36.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.21 billion (Q2 2026), $839.47 million (Q1 2026) and $916.98 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn | 1.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.19 Bn |
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | 839.47 Mn |
| Dec 31, 2025 | 916.98 Mn |
| Sep 30, 2025 | 977.35 Mn |
| Jun 30, 2025 | 886.54 Mn |
| Mar 31, 2025 | 956.05 Mn |
| Dec 31, 2024 | 1.11 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 638.70 Mn |
| Dec 31, 2023 | 628.05 Mn |
| Sep 30, 2023 | 561.42 Mn |
| Jun 30, 2023 | 586.58 Mn |
| Mar 31, 2023 | 680.63 Mn |
| Dec 31, 2022 | 795.19 Mn |
| Sep 30, 2022 | 884.28 Mn |
| Jun 30, 2022 | 602.25 Mn |
| Mar 31, 2022 | 623.53 Mn |
| Dec 31, 2021 | 535.67 Mn |
API Access
Cytokinetics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();